Copyright
©The Author(s) 2021.
World J Gastrointest Oncol. Apr 15, 2021; 13(4): 238-251
Published online Apr 15, 2021. doi: 10.4251/wjgo.v13.i4.238
Published online Apr 15, 2021. doi: 10.4251/wjgo.v13.i4.238
Advantages | Disadvantages | |||
No pre-colonoscopy consultations | Promotes development of an electronic risk-assessment system | Increased rates of inappropriate surveillance guidelines | Dependent on hospital infrastructure to facilitate OAC | High rates of no-shows and cancellations |
Decreased healthcare expenditure | Shared medical records amongst patient’s care team | May take away from limited available resources | Loss of appointment spots needed to make up for COVID-19 backlog | |
Patients save time and money | Identifies high risk individuals | |||
Decreased patient load on gastroenterologists | Recommends screening based on most recent CRC guidelines |
- Citation: Kadakuntla A, Wang T, Medgyesy K, Rrapi E, Litynski J, Adynski G, Tadros M. Colorectal cancer screening in the COVID-19 era. World J Gastrointest Oncol 2021; 13(4): 238-251
- URL: https://www.wjgnet.com/1948-5204/full/v13/i4/238.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v13.i4.238